Journal Mobile Options
Table of Contents
Vol. 13, No. 1, 2007
Issue release date: December 2006
Eur Addict Res 2007;13:11–19
(DOI:10.1159/000095810)

Crack Cocaine: A Five-Year Follow-Up Study of Treated Patients

Ribeiro M. · Dunn J. · Sesso R. · Lima M.S. · Laranjeira R.
aUnidade de Pesquisa em Ðlcool e Drogas, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; bNorth Camden Drug Service, Camden and Islington Mental Health and Social Care Trust, London, UK; cGrupo Interdepartamental de Epidemiologia Clinica, Federal University of São Paulo, São Paulo, and dEli Lilly Brazil, Federal University of Pelotas, Catholic University of Pelotas, Pelotas, Brazil

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Objectives: To follow-up a group of 131 crack cocaine users and examine drug use, treatment experience, employment status, involvement in crime and mortality at 2 and 5 years. Methods: Consecutive crack-dependent patients who were admitted to a detoxification unit in São Paulo between 1992 and 1994 were re-interviewed on two occasions: 1995–1996 and 1998–1999. Results: 5 years after treatment information was obtained on 124 (95%) of the original cohort. 39.7% (n = 52) of the patients reported having been abstinent from cocaine for at least the last year, and 21.4% (n = 28) had used the drug. Of those subjects not using cocaine at 2 years, 19 (62%) were still abstinent at 5 years. Twenty-three (17.6%) patients had died by the 5-year follow-up with homicide, due to firearms or other weapons, being the commonest cause (n = 13). The annual adjusted mortality rate for the sample was 24.92 deaths/1,000 individuals, the excess mortality rate was of 21.64 deaths/1,000 individuals, and the standardized mortality ratio was 7.60. A history of injecting drug use, unemployment at the time of the index admission and administrative discharge at the index admission were factors that contributed to the risk of dying over the next 5 years. Conclusions: There was a progressive movement towards abstinence over the follow-up period, and there was evidence that once abstinence had been achieved it was maintained. On the other hand, the mortality rate was extremely high and was higher among those who were still using crack at 2 years.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. United Nations Office on Drugs and Crime (UNODC): Annual prevalence of drug abuse – cocaine; in: UNODC. World Drug Report – 2005. New York, UNO, 2005. http://www.unodc.org/unodc/world_drug_report.html
  2. Haasen C, Prinzleve M, Zurhold H, Rehm J, Guttinger F, Fischer G, Jagsch R, Olsson B, Ekendahl M, Verster A, Camposeragna A, Pezous AM, Gossop M, Manning V, Cox G, Ryder N, Gerevich J, Bacskai E, Casas M, Matali JL, Krausz M: Cocaine use in Europe – a multi-centre study. Methodology and prevalence estimates. Eur Addict Res 2004;10:139–146.
  3. Dunn J, Laranjeira R, Silveira DX, Formigoni MLOS, Ferri CP: Crack cocaine: an increase in use among patients attending clinics in São Paulo: 1990–1993. Subst Use Misuse 1996;31:519–527.
  4. Nappo SA, Galduroz JC, Raymundo M, Carlini EA: Changes in cocaine use as viewed by key informants: a qualitative study carried out in 1994 and 1999 in São Paulo, Brazil. J Psychoactive Drugs 2001;33:241–253.
  5. Dunn J, Laranjeira R: Cocaine – profiles, drug histories, and patterns of use of patients from Brazil. Substance Use Misuse 1999;34:1527–1548.
  6. Brain K, Parker H, Bottomley T: Evolving Crack Cocaine Careers: New Users, Quitters and Long Term Combination Drug Users in N.W. England. Manchester, University of Manchester, 1998. http://www.homeoffice.gov.uk/rds/pdfs/r85.pdf
  7. Falck RS, Wang J, Siegal HA, Carlson RG: Longitudinal application of the Mental Outcome Study 36-Item Short-Form Health Survey with not-in-treatment crack-cocaine users. Med Care 2000;38:902–910.
  8. Gossop M, Marsden J, Stewart D, Kidd T: Changes in use of crack cocaine after drug misuse treatment: 4–5 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug Alcohol Depend 2002;66:21–28.

    External Resources

  9. Siegal HA, Li L, Rapp RC: Abstinence trajectories among treated crack cocaine users. Addict Behav 2002;27:437–449.
  10. Simpson DD, Joe GW, Broome KM: A national 5-year follow-up of treatment outcomes for cocaine dependence. Arch Gen Psychiatry 2002;59:538–544.
  11. McKay JR, Foltz C, Stephens RC, Leahy PJ, Crowley EM, Kissin W: Predictors of alcohol and crack cocaine use outcomes over a 3-year follow-up in treatment seekers. J Subst Abuse Treat 2005;28(suppl 1):S73–S82.

    External Resources

  12. Ribeiro M, Dunn J, Laranjeira R, Sesso R: High mortality among young crack cocaine users in Brazil: a 5-year follow-up study. Addiction 2004;99:1133–1135.
  13. Laranjeira R, Rassi R, Dunn J, Fernandes M, Mitsuhiro S: Crack cocaine – a two-year follow-up of treated patients. J Addict Dis 2001;20:43–48.
  14. Anderson RN, Rosenberg HM: Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep 1998;47:1–16, 20. http://www.cdc.gov/nchs/data/nvsr/nvsr47/nvsr47_03.pdf
  15. Hser YI, Joshi V, Anglin MD, Fletcher B: Predicting posttreatment cocaine abstinence for first-time admissions and treatment repeaters. Am J Public Health 1999;89:666–671.
  16. Alterman AI, McKay JR, Mulvaney FD, Cnaan A, Cacciola JS, Tourian KA, Rutherford MJ, Merikle EP: Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients. Drug Alcohol Depend 2000;59:215–221.
  17. Sánchez-Carbonell X, Seus L: Ten-year survival analysis of a cohort of heroin addicts in Catalonia: the EMETYST Project. Addiction 2000;95:941–948.
  18. Goldstein A, Herrera J: Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995;40:139–150.
  19. Blumstein A, Rivara FP, Rosenfeld, R: The rise and decline of homicide – and why. Annu Rev Public Health 2000;21:505–541.
  20. Oppenheimer E, Tobutt C, Taylor C, Andrew T: Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction 1994;89:1299–1308.
  21. Frischer M, Goldberg D, Rahman M, Berney L: Mortality and survival among a cohort of drug injectors in Glasgow, 1982–1994. Addiction 1997;92:419–427.
  22. Quaglio G, Talamini G, Lechi A, Venturini L, Lugoboni F, Mezzelani P; Gruppo Intersert di Collaborazione Scientifica (GICS): Study of 2708 heroin-related deaths in north-eastern Italy 1985–98 to establish the main causes of death. Addiction 2001;96:1127–1137.
  23. Hser Y-I, Hoffman V, Grella CE, Anglin D: A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503–508.
  24. Termorshuizen F, Krol A, Prins M, van Ameijden EJ: Long-term outcome of chronic drug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol. 2005;161:271–279.
  25. Fugeldtad A, Annell A, Rajs J, Ågren G: Mortality and causes as manner of death among drug addicts in Stockholm during the period 1981–1992. Acta Psychiatr Scand 1997;96:169–175.
  26. Ghodse H, Oyefeso A, Kilpatrick B: Mortality of drug addicts in the United Kingdom 1967 – 1993. Int J Epidemiol 1998;27:473–478.
  27. Oyefeso A, Ghodse H, Clancy C, Corkery J, Goldfinch R: Drug abuse-related mortality: a study of teenage addicts over a 20-year period. Soc Psychiatry Psychiatr Epidemiol 1999;34:437–441.
  28. Neumark YD, Etten MLV, Anthony JC: ‘Drug dependence’ and death: survival analysis of the Baltimore ECA from 1981 to 1995. Subst Use Misuse 2000;35:313–327.
  29. Budd RD: Cocaine abuse and violent death. Am J Drug Alcohol Abuse 1989;15:375–382.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50